Lymphopenia combined with low TCR diversity to predict overall survival in metastatic breast cancer patients.
Manuarii Manuel
Employment or Leadership Position - ImmunID Technologies (U)
Consultant or Advisory Role - ImmunID Technologies (U)
Research Funding - ImmunID Technologies
Other Remuneration - ImmunID Technologies
Olivier Tredan
No relevant relationships to disclose
Thomas Bachelot
No relevant relationships to disclose
Gilles Clapisson
No relevant relationships to disclose
Anais Courtier
Employment or Leadership Position - ImmunID Technologies (U)
Gilles Parmentier
Employment or Leadership Position - ImmunID Technologies (U)
Consultant or Advisory Role - ImmunID Technologies (U)
Audrey Grives
Employment or Leadership Position - ImmunID Technologies (U)
Research Funding - ImmunID Technologies
Solene Perez
Employment or Leadership Position - ImmunID Technologies (U)
Research Funding - ImmunID Technologies
Jean-Francois Mouret
Employment or Leadership Position - ImmunID Technologies (U)
Consultant or Advisory Role - ImmunID Technologies (U)
Research Funding - ImmunID Technologies
David Perol
No relevant relationships to disclose
Sylvie Chabaud
No relevant relationships to disclose
Isabelle Ray-Coquard
No relevant relationships to disclose
Sana Intidhar Labidi-Galy
No relevant relationships to disclose
Pierre Heudel
No relevant relationships to disclose
Jean-Yves Pierga
No relevant relationships to disclose
Christophe Caux
No relevant relationships to disclose
Jean-Yves Blay
No relevant relationships to disclose
Nicolas Pasqual
Employment or Leadership Position - ImmunID Technologies (U)
Stock Ownership - ImmunID Technologies
Research Funding - ImmunID Technologies
Other Remuneration - ImmunID Technologies
Christine Menetrier-Caux
No relevant relationships to disclose